https://orcid.org/0000-0003-1246-3048
Figures & data
Table 1. Baseline characteristics of total patient group and patients with EGFR-mutated tumours (EGFR mut) and non-EGFR-mutated tumours (EGFR non-mut), respectively.
Figure 1. Overall survival (A, left), Relapse-free survival (A, middle), Relapse-free cause-specific survival (A, right) and Cause of death (B) among EGFR-mutated and -nonmutated surgically resected lung adenocarcinoma. Time zero is date of surgery.
Table 2. Multivariate analyses of overall survival, relapse free survival and survival after relapse.
Figure 2. Relapse pattern among EGFR-mutated and -nonmutated surgically resected lung adenocarcinoma.
Figure 3. Time from first relapse to all-cause death among EGFR-mutated and -nonmutated surgically resected lung adenocarcinoma.
Figure 4. Swimmer plot of EGFR-mutated patients relapsing after surgery, and treatment type. Patients with brain metastasis are noted on the y-axis. Arrows indicate patients still alive at data cut-off.
